IBD Research summit set for Oct. 18

Make plans now to attend the Inflammatory Bowel Disease (IBD) Research Summit from 7:30 a.m. to 3 p.m. on Oct. 18, at the University Conference Center on the campus of Penn State Milton S. Hershey Medical Center. The summit will provide an update on IBD research at Penn State College of Medicine, promote awareness and collaboration between scientists and clinicians, and discuss how to develop pilot projects using an IBD biobank.

The keynote speaker for the day is Dr. Dermot McGovern, director of translational medicine, F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles; professor of medicine, Cedars-Sinai Medical Center, and clinical professor of Medicine, David Geffen School of Medicine, University of California in Los Angeles (UCLA); and the Joshua and Lisa Greer Endowed Professor of IBD Genetics, Cedars-Sinai Medical Center. Considered a world leader in the genetic study of Inflammatory Bowel Disease, McGovern will present, “IBD—The Prototype for Translational Medicine?”

The program is a continuing education service of Penn State College of Medicine and Penn State Hershey Inflammatory Bowel Disease Center.

There is no fee for this program, but preregistration at pennstatehershey.org/web/ce is required. The University reserves the right to cancel or postpone any course or activity because of insufficient enrollment or other unforeseen circumstances.

Media Contacts: 
Last Updated October 09, 2013